| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
3 companies
Broadwood Partners, L.P. is a Director, 10% Owner at Lineage Cell Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 54 buys and 0 sells.
Estimated insider holdings value: $543.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 201,844 | $17.77 | $3,586,282.98 | +0.3% | -6.0% | -2.2% | |
| Mar 4, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 27,953 | $17.24 | $481,849.07 | - | -6.0% | +8.2% | |
| Mar 3, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 663,761 | $16.99 | $11,275,554.82 | +0.5% | +1.3% | +14.9% | |
| Feb 14, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 411,430 | $15.25 | $6,274,766.53 | +0.4% | +19.2% | +4.9% | |
| Feb 6, 2025 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 5,165,695 | $2.05 | $10,589,674.75 | +16.4% | +38.0% | +257.1% | |
| Jan 27, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Director, 10% Owner | Buy | 7,894,737 | $0.76 | $6,000,000.12 | +8.7% | -25.2% | +165.0% | |
| Jan 16, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 29,376 | $21.47 | $630,838.87 | - | -26.1% | -4.0% | |
| Dec 18, 2024 | STAA Staar Surgical Co | 10% Owner | Buy | 80,200 | $24.28 | $1,947,539.94 | - | -24.6% | -1.0% | |
| Oct 2, 2024 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 1,315,339 | $2.95 | $3,877,619.37 | +11.8% | -22.0% | +9.5% | |
| May 9, 2024 | STAA Staar Surgical Co | 10% Owner | Buy | 1 | $42.56 | $42.56 | - | -15.2% | -54.7% |